1. Home
  2. VITL vs FTRE Comparison

VITL vs FTRE Comparison

Compare VITL & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vital Farms Inc.

VITL

Vital Farms Inc.

HOLD

Current Price

$20.14

Market Cap

944.3M

ML Signal

HOLD

Logo Fortrea Holdings Inc.

FTRE

Fortrea Holdings Inc.

HOLD

Current Price

$10.37

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VITL
FTRE
Founded
2007
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Medical Specialities
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
944.3M
1.5B
IPO Year
2020
2023

Fundamental Metrics

Financial Performance
Metric
VITL
FTRE
Price
$20.14
$10.37
Analyst Decision
Strong Buy
Buy
Analyst Count
9
9
Target Price
$42.56
$15.39
AVG Volume (30 Days)
2.1M
2.0M
Earning Date
01-01-0001
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
22.03
N/A
EPS
1.44
N/A
Revenue
$759,444,000.00
$2,723,400,000.00
Revenue This Year
$26.07
N/A
Revenue Next Year
$20.95
$2.96
P/E Ratio
$13.90
N/A
Revenue Growth
25.26
1.00
52 Week Low
$19.75
$3.97
52 Week High
$53.13
$18.67

Technical Indicators

Market Signals
Indicator
VITL
FTRE
Relative Strength Index (RSI) 23.04 32.76
Support Level N/A $9.35
Resistance Level $29.73 $11.41
Average True Range (ATR) 1.34 1.01
MACD -0.63 0.08
Stochastic Oscillator 2.93 57.60

Price Performance

Historical Comparison
VITL
FTRE

About VITL Vital Farms Inc.

Vital Farms Inc is an ethical food company. The company retails pasture-raised eggs and butter. Its products include Pasture-Raised Eggs and Pasture-Raised Butter & Ghee. The company's purpose is rooted in a commitment to Conscious Capitalism, which prioritizes the long-term benefits of its stakeholders (farmers and suppliers, customers and consumers, communities and the environment, employees, and stockholders).

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: